Accéder au contenu
Merck

GT1b in human metastatic brain tumors: GT1b as a brain metastasis-associated ganglioside.

Biochimica et biophysica acta (1999-02-05)
H Hamasaki, M Aoyagi, T Kasama, S Handa, K Hirakawa, T Taki
RÉSUMÉ

We studied ganglioside expression in 12 human metastatic brain tumors metastasized from colon (4), renal (3), lung (2), esophagus (1), pancreas (1), and mammary (1) carcinomas. GM3 was the major common ganglioside expressed in brain metastatic tumor tissues, and GT1b was also present in all the metastatic brain tumor tissues. The latter was identified by TLC-immunostaining and characterized structurally by secondary ion mass spectrometry combined with 'Far-Eastern blot'. The immunohistochemical analysis of frozen tissue sections confirmed localization of GT1b in the tumor cell membrane or cytosol. GT1b was shown to be expressed both in the primary colon carcinoma and the metastasis of a single patient by immunohistochemical procedure. In systemic carcinomas without brain metastasis, GM3 was a common major component, but no GT1b was detected. These findings indicate that GT1b is a brain metastasis-associated ganglioside. We speculate that the presence of GT1b would be a useful marker for estimating metastatic potentials to the brain.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Trisialoganglioside-GT1b from bovine brain, lyophilized powder, ≥96% (TLC)